Ticker

6/recent/ticker-posts

Header Ads Widget

BREAKING: FG Develops Sickle Cell Vaccine

 

Nigeria has achieved a new milestone after the Ministry of Science Technology and Innovation developed sickle cell and venom vaccines.

 

The Minister of Science Technology and Innovation, Adeleke Mamora, announced the news while speaking on Monday at the 10th edition of the PMB Administration Scorecard Series (2015-2023).

 

Mamora said the ministry achieved the use of local herbs for the production of drugs for sickle cell as the country had a high number of people with sickle cell anaemia.

 

Also announcing some of the achievements of his ministry, Mamora added; 

 

“There is also the development of an anti-venom vaccine, an anti-penic that reduces fat in the body.


“The Ministry, through Raw Materials Research and Development Council’s programme on development of the dairy sector, introduced the technology of increasing daily milk yield from our cows from 1-1.5 litres of milk per cow to over 15 litres per cow in a day.


“The National Space Research and Development Agency is working to establish a Space Museum and Planetarium that is expected to realise about N30 billion, boost tourism activities, provide 5000 direct jobs; 20,000 indirect jobs and improve the teaching of STI.


“Our future is full of optimism as long as we keep faith and leverage on the enormous power of STI coupled with demand-driven R&D programmes and projects.


“The fourth industrial revolution will register Nigeria’s presence and effective participation if we sustain and escalate current commitment and interest in research and innovation as principal push factors for technological advancement.


“We need courage, discipline and focus on fundamental principles of the culture of result-based management logical framework where all policy implementation efforts will produce outcomes.” 

Do you have any information or event for ABUJAPRESS to publish or cover? Kindly Call us on +2349075556668 or send us message on Whatsapp number +2348037780342 or send us an email [email protected]

Post a Comment

0 Comments